Animal study · pigs and marmoset monkeys

IGF-1 LR3 lowered blood sugar longer than native IGF-I in pigs

Checked against the paper Animal studyPublished by PepVault

The takeaway

In pigs, one injection of IGF-1 LR3 lowered blood sugar more strongly and for longer than native IGF-I did.

Kind
Animal study
Studied in
Pigs and marmoset monkeys
Published
1997
Journal
J Endocrinol

What they tested

The team tested whether IGF-I variants that bind weakly to IGF-binding proteins lower blood sugar more strongly or for longer than native IGF-I.

How the study was done

An animal study in which pigs got a single injection of IGF-I, one of four variants including IGF-1 LR3 (20 or 50 micrograms/kg), or insulin (3 micrograms/kg), while marmoset monkeys got IGF-I or des(1-3)IGF-I (42 to 270 micrograms/kg). Blood was sampled from 30 min before to 4 h after each injection.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking IGF-1 LR3? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In pigs and marmosets, plasma glucose fell more as the dose rose, with the largest drops at 4.8 mmol/l in pigs, 3.7 in awake marmosets and 2.5 in anesthetized marmosets. The variants were 2- to 3-fold more potent than IGF-I at pushing glucose to its lowest point, and IGF-1 LR3 ranked about level with R3IGF-I, behind only des(1-3)IGF-I. Over the 4 hours, the total glucose lowering from the variants was about 4- to 8-fold greater than IGF-I, and about 2-fold greater at doses that gave the same lowest point. In pigs, IGF-1 LR3 was the only variant that lowered plasma amino acids more strongly than IGF-I, and this effect was stronger at the higher dose.

What it doesn’t show

This was a short animal study of single injections followed for 4 hours, so it is not a human result and says nothing about repeated use. IGF-1 LR3 was tested only in pigs, not in the marmosets.

The paper

Tomas et al. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. J Endocrinol. 1997.

The compound

More studies on IGF-1 LR3

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking IGF-1 LR3? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo